Tag: Organ Transplants
Good Long-Term Survival After Childhood Liver Transplant
20-year survival almost 80 percent; over one-third of patients have CKD, altered liver biochemistries
Targeting Ups Nanoparticle Delivery to Graft Endothelial Cells
Anti-CD31 antibody selectively enhances targeting of NPs to graft ECs of human kidney undergoing NMP
Monoclonal Antibodies Cut Ischemia-Reperfusion Injury
In animal model, anti-CD47 monoclonal antibody group had decease in injury of renal allografts
ASN: Nonmedical Factors Impact Kidney Transplant Waits
African-Americans less likely to be wait-listed; higher income positively associated with wait-listing
In Norway, Risk of SCC After Organ Transplant Has Fallen
Standardized incidence ratio peaked in patients who underwent transplantation in 1983-1987 period
Visceral Adipose Tissue Index IDs Risk of HCC in Cirrhosis
High VATI is also linked to risk of HCC recurrence in males with HCC who underwent liver transplant
Demand for Liver Transplant for NASH Set to Continue Rising
Increase in obesity prevalence strongly linked to liver transplant waitlist additions nine years later
Graft Survival Similar for Kidneys From Octogenarians
Recipients of biopsy-guided kidneys from >80-year-old donors had significantly shorter waiting times
Factors Unrelated to Allograft Quality Tied to Organ Turndown
Holiday or weekend procurement, shorter donor stature, location of procurement tied to later acceptance
ABO Incompatible Dual Graft Living Donor Liver Transplant Viable
High graft survival at one-, three-, five-years; no significant difference for ABO compatible, incompatible
